Home › Funds › Renaissance Technologies › IBRX
Renaissance Technologies position in IBRX
IMMUNITYBIO INC · Health Care
Latest position (Q2 2026)1.03M sh
Reported value held$9.01M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 207.92K | $2.02M | New |
| Q4 2021 | 304.90K | $1.85M | Add |
| Q2 2022 | 401.68K | $1.49M | New |
| Q3 2025 | 1.02M | $2.50M | New |
| Q4 2025 | 1.23M | $2.44M | Add |
| Q2 2026 | 1.03M | $9.01M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IBRX
- BlackRock Inc 34.08M sh · $298.40M · Q2 2026
- D. E. Shaw & Co 11.55M sh · $101.13M · Q2 2026
- Two Sigma Investments 11.10M sh · $97.16M · Q2 2026
- Geode Capital Management 9.85M sh · $86.23M · Q2 2026
- Vanguard Group 32.78M sh · $64.90M · Q4 2025
- Millennium Management 5.58M sh · $48.85M · Q2 2026
- Northern Trust Corp 3.57M sh · $31.21M · Q2 2026
- Morgan Stanley 3.43M sh · $30.05M · Q2 2026
- Goldman Sachs Group 3.23M sh · $28.32M · Q2 2026
- UBS Group AG 3.20M sh · $27.98M · Q2 2026
- Charles Schwab Investment Management 2.89M sh · $25.29M · Q2 2026
- Bank of America Corp 2.18M sh · $19.13M · Q2 2026